A New Immunotherapy Drug Creates a Watershed for the Surgical Pathologist's Role in Patient Care

Arch Pathol Lab Med. 2015 Nov;139(11):1329. doi: 10.5858/arpa.2015-0901-ED.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / therapeutic use
  • B7-H1 Antigen / immunology
  • B7-H1 Antigen / metabolism
  • Biomarkers, Tumor / immunology
  • Biomarkers, Tumor / metabolism
  • Carcinoma, Non-Small-Cell Lung / immunology
  • Carcinoma, Non-Small-Cell Lung / metabolism
  • Carcinoma, Non-Small-Cell Lung / therapy
  • Humans
  • Immunohistochemistry
  • Immunotherapy / methods*
  • Lung Neoplasms / immunology
  • Lung Neoplasms / metabolism
  • Lung Neoplasms / therapy
  • Nivolumab
  • Pathology, Surgical / methods*
  • Patient Care / methods*
  • Physician's Role*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • B7-H1 Antigen
  • Biomarkers, Tumor
  • CD274 protein, human
  • Nivolumab